JSPR

Jasper Therapeutics, Inc. JSPR

$0.88 +0.11 (+14.34%)

Blow-off · +2.33σ Hot zone

+ Compare Open in Sniper

Mkt cap $0.0B

P/E —

Day $0.58 – $1.03

52wk $0.31 – $1.65

Avg vol —

Beta —

Div yld —

Next earnings —

Quick read

Plain English

Jasper Therapeutics, Inc. is a healthcare company listed in the US.

JSPR last traded at $0.88, up 14.3% on the day; that's in the middle part of its 52-week range ($0.31–$1.65). Right now it's stretched well above its recent average — moves this fast often cool off or give some back.

Earnings reports are the biggest scheduled catalysts to keep an eye on, and after a strong run, watch whether the price can hold its gains on quieter days.

A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.

132-Day Trend Zones

Full chart →

21 EMA +1 ATR +2 ATR −2 ATR

—

O — H — L — C —

— —

Under the hood

On the latest daily bar, momentum is running hot (RSI 74, overbought territory), the trend is strong (ADX 28), and trading is unusually heavy at 9.6× normal volume.

Latest-bar indicator readings behind the grade — display-only, they don't move the letter.

Momentum · RSI

0–100 · <30 oversold

Trend strength · ADX

>25 = strong trend

Volume vs avg

9.56×

1× = average

Stretch from avg

+2.5 ATR

− below · + above

Zone touches

tests of this zone

Suggested hold

5–60

bars (≈ days)

Fundamentals at a glance

Company fundamentals for context — display-only, they don't move the grade.

Debt / equity

0.22

lower = less leveraged

Valuation & accounting

Valuation desk →

The model's verdict is “Unknown” and accounting quality screens as Weak. Model estimates only — do your own due diligence.

Verdict

Unknown

Accounting quality Weak

✓ More cash than debt
✓ Current ratio 2.62 (antifragile)

⚠ Debt/equity 7.62 (fragile)
⚠ Negative retained earnings

Key statistics

All statistics →

JSPR is a $17 million company.

Mkt cap $0.0B

P/E ttm —

Fwd P/E —

Beta —

Day range $0.58 – $1.03

52w range $0.31 – $1.65

Avg vol —

RSI(2) 95.6

ROE —

Net mgn —

FCF mgn —

Debt/Eq 0.22

Div yld —

Sector Healthcare

Industry Biotechnology

Next earn —

52-week range · today's price

$0.31$1.65